OFFIDANI, MICHELE
OFFIDANI, MICHELE
DIPARTIMENTO DI CHIMICA INDUSTRIALE "TOSO MONTANARI"
Dottorandi
18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease
2016 Zamagni, E; Nanni, C; Gay, F; Pezzi, A; Patriarca, F; Bellò, M; Rambaldi, I; Tacchetti, P; Hillengass, J; Gamberi, B; Pantani, L; Magarotto, V; Versari, A; Offidani, M; Zannetti, B; Carobolante, F; Balma, M; Musto, P; Rensi, M; Mancuso, K; Dimitrakopoulou-Strauss, A; Chauviè, S; Rocchi, Serena; Fard, N; Marzocchi, G; Storto, G; Ghedini, P; Palumbo, A; Fanti, S; Cavo, M
A Comprehensive Review on Two-Step Thermochemical Water Splitting for Hydrogen Production in a Redox Cycle
2022 Daphne Oudejans; Michele Offidani; Achilleas Constantinou; Stefania Albonetti; Nikolaos Dimitratos; Atul Bansode
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients
2022 Morabito F.; Zamagni E.; Conticello C.; Pavone V.; Palmieri S.; Bringhen S.; Galli M.; Mangiacavalli S.; Derudas D.; Rossi E.; Ria R.; Catalano L.; Tacchetti P.; Mele G.; Donatella Vincelli I.; Antonia Martino E.; Vigna E.; Botta C.; Bruzzese A.; Mele A.; Pantani L.; Rocchi S.; Garibaldi B.; Cascavilla N.; Ballanti S.; Tripepi G.; Frigeri F.; Pia Falcone A.; Cangialosi C.; Reddiconto G.; Farina G.; Barone M.; Rizzello I.; Musto P.; De Stefano V.; Musso M.; Teresa Petrucci M.; Offidani M.; Neri A.; Di Renzo N.; Di Raimondo F.; Boccadoro M.; Cavo M.; Gentile M.
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Solar-driven valorization of glycerol towards production of chemicals and hydrogen
2021 Maslova V.; Fasolini A.; Offidani M.; Albonetti S.; Basile F.
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
2023 van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadisseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M, Gay F, Sonneveld P, Musto P
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| 18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease | Zamagni, E; Nanni, C; Gay, F; Pezzi, A; Patriarca, F; Bellò, M; Rambaldi, I; Tacchetti, P; Hillen...gass, J; Gamberi, B; Pantani, L; Magarotto, V; Versari, A; Offidani, M; Zannetti, B; Carobolante, F; Balma, M; Musto, P; Rensi, M; Mancuso, K; Dimitrakopoulou-Strauss, A; Chauviè, S; Rocchi, Serena; Fard, N; Marzocchi, G; Storto, G; Ghedini, P; Palumbo, A; Fanti, S; Cavo, M | 2016-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | zamagni.pdf |
| A Comprehensive Review on Two-Step Thermochemical Water Splitting for Hydrogen Production in a Redox Cycle | Daphne Oudejans; Michele Offidani; Achilleas Constantinou; Stefania Albonetti; Nikolaos Dimitrato...s; Atul Bansode | 2022-01-01 | ENERGIES | - | 1.01 Articolo in rivista | energies-15-03044-v2 (1).pdf |
| Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients | Morabito F.; Zamagni E.; Conticello C.; Pavone V.; Palmieri S.; Bringhen S.; Galli M.; Mangiacava...lli S.; Derudas D.; Rossi E.; Ria R.; Catalano L.; Tacchetti P.; Mele G.; Donatella Vincelli I.; Antonia Martino E.; Vigna E.; Botta C.; Bruzzese A.; Mele A.; Pantani L.; Rocchi S.; Garibaldi B.; Cascavilla N.; Ballanti S.; Tripepi G.; Frigeri F.; Pia Falcone A.; Cangialosi C.; Reddiconto G.; Farina G.; Barone M.; Rizzello I.; Musto P.; De Stefano V.; Musso M.; Teresa Petrucci M.; Offidani M.; Neri A.; Di Renzo N.; Di Raimondo F.; Boccadoro M.; Cavo M.; Gentile M. | 2022-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B....; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | 2020-01-01 | THE LANCET. HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Solar-driven valorization of glycerol towards production of chemicals and hydrogen | Maslova V.; Fasolini A.; Offidani M.; Albonetti S.; Basile F. | 2021-01-01 | CATALYSIS TODAY | - | 1.01 Articolo in rivista | 2021 Albonetti CT con Copertina_postprint_IRIS_UNIBO.pdf |
| Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study | van de Donk NWCJ, Minnema MC, van der Holt B, Schjesvold F, Wu KL, Broijl A, Roeloffzen WWH, Gadi...sseur A, Pietrantuono G, Pour L, van der Velden VHJ, Lund T, Offidani M, Grasso M, Giaccone L, Razawy W, Tacchetti P, Mancuso K, Silkjaer T, Caers J, Zweegman S, Hájek R, Benjamin R, Vangsted AJ, Boccadoro M, Gay F, Sonneveld P, Musto P | 2023-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |